RYLPF:OTC-Koninklijke Philips N.V (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 25.45

Change

+0.82 (+3.34)%

Market Cap

USD 22.19B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional X-ray systems and software solutions; and interventional image devices and software to aid in the diagnosis, navigation, treatment, and confirmation in minimally invasive interventional coronary, peripheral vascular, and hearth rhythm management procedures. The company also offers acute patient management solutions; emergency care solutions; patient care management in ambulatory and home care; sleep and respiratory care solutions; and vendor-agnostic software solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental and women's health solutions; and grooming and beauty products and solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-05 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
SMMNY Siemens Healthineers AG ADR

-0.04 (-0.15%)

USD 55.86B
SEMHF Siemens Healthineers AG

+0.48 (+0.88%)

USD 54.79B
SONVF Sonova Holding AG

N/A

USD 16.41B
OCPNF Olympus Corporation

N/A

USD 14.51B
SNNUF Smith & Nephew plc

+0.17 (+1.20%)

USD 12.54B
SSMXF Sysmex Corporation

N/A

USD 11.54B
WILLF Demant A/S

N/A

USD 6.94B
AMBBY Ambu A/S

N/A

USD 4.72B
GGNDF GN Store Nord A/S

-2.03 (-13.51%)

USD 2.18B
NHNKY Nihon Kohden Corp ADR

+0.28 (+2.22%)

USD 2.11B

ETFs Containing RYLPF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.79% 63% D 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.79% 62% D 47% F
Trailing 12 Months  
Capital Gain -5.46% 65% D 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.46% 65% D 48% F
Trailing 5 Years  
Capital Gain -39.58% 60% D- 39% F
Dividend Return 6.24% 47% F 13% F
Total Return -33.34% 63% D 38% F
Average Annual (5 Year Horizon)  
Capital Gain -5.81% 45% F 31% F
Dividend Return -5.81% 45% F 28% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 38.63% 72% C 59% D-
Risk Adjusted Return -15.04% 42% F 29% F
Market Capitalization 22.19B 98% N/A 95% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector